GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                            
                                
                                                                Synonyms: LCQ-908 | LCQ908
                                 
                                                         
                            Compound class: 
                                                            Synthetic organic
                                 
                                
                                    
                                        Comment: Pradigastat is a potent and selective inhibitor of diacylglycerol O-acyltransferase 1 (DGAT1). 
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                      
                                     
                                   
                                   
                                    
                                    
                                    The PubChem CID 53387035 shows the molecule with no stereochemistry.  | 
                                    
                                        
                                         
  | 
                                    
                                
                                |||||||||||||||||||||||||||||||||||
| References | 
| 
                                                                         1. Meyers C, Gaudet D, Tremblay K, Amer A, Chen J, Aimin F. (2012)
                                         The DGAT1 inhibitor LCQ908 decreases triglyceride levels in patients with the familial chylomicronemia syndrome. Journal of Clinical Lipidology, 6: 266-267.  | 
                                                                
| 
                                                                         2. Novartis. 
                                         CLCQ908 Type 2 Diabetes Mellitus (T2DM). Accessed on 29/10/2014. Modified on 29/10/2014. Novartis Clinical Trial Results Database, http://www.novctrd.com/ctrdWebApp/clinicaltrialrepository/public/product.jsp?divisionId=2&productID=417&diseaseAreaID=5  |